ASAP News

In recent years, opioid painkillers have emerged as a major cost driver.  The high costs impact employers, who endure increased worker’s compensation claims and decreased productivity.  According to a NYTimes.com article citing a 2010 analysis by Accident Fund Holdings (a […]

In May ASAP welcomed drug testing industry veteran Dr. Christian Jensen.  Dr. Jensen shared with ASAP team members, details on the DOT drug testing procedures and his insight on the progression of the industry over the years.  Dr Jensen is

On May 17, 2012, the Federal Railroad Administration (FRA) issued a notice of proposed rule-making (NPRM) to add potentially impairing non-controlled substances to its standard post-accident testing panel.  According to FRA research, prescription and over-the-counter (OTC) drug use has become

Morphine, an alkaloid found in opium can be detected in the body after the use of opioids such as codein, heroin and morphine sulfate.  6-acetylmorphine (6-AM) is a metabolite that is unique to only heroin.   Its presence in urine indicates

The New Paradigm for Long Term Recovery was the buzz at this year’s DATIA annual conference in San Antonio, TX.  The crowd was engaged by keynote speaker Dr. Robert Dupont, the former White House Drug Czar, founding director of the

On April 17th the Obama Administration released the 2012 National Drug Control Strategy.  The goal of strategy is to be a blueprint for reducing drug use and its consequences.    According to the document, “Illicit drug use in America contributed to

On Tuesday, April 10, 2012, the DOT issued a reminder about important 40 CFR Part 40 regulatory requirements to Medical Review Officers (MROs), Consortia/Third Party Administrators (C/TPAs), collectors and employers.  The following are the key points. The MRO’s name, address,

Reed Morrison, Ph.D. will deliver a presentation on Thursday, April 19th to the attendees of this year’s annual DATIA Conference.  The conference which will be held on April 18th – 20th in San Antonio, TX is a gathering of drug

Companies that are required to conduct random drug and alcohol testing under the DOT are subject to many rules to ensure compliance throughout the process.  Listed below are a few tips to help complete the random testing process successfully. #1:

Molly, derived from the word molecule is commonly used as a recreational drug.  The chemical make-up is 4-Methylmethcathinone (4-MMC) and 4-Methyl-N-Ethylcathinone (4-MEC) or MDMA.  4-MMC and 4-MEC are controlled substance analogues of methcathinone, a Schedule I controlled substance.  Molly, is